Contraception Clinical Trial
Official title:
A Randomised Controlled Trial of an Intervention Delivered by App Instant Messaging to Increase Use of Effective Contraception Among Young Women in Bolivia
Verified date | September 2017 |
Source | London School of Hygiene and Tropical Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on use of effective contraception in Bolivia. Woman aged 16-24 will be randomised to have access to Centro de Investigacion, Educacion y Servicios's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 month follow-up.
Status | Completed |
Enrollment | 645 |
Est. completion date | January 31, 2018 |
Est. primary completion date | January 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 16 Years to 24 Years |
Eligibility |
Inclusion Criteria: - Aged 16-24 - Own a personal Android mobile phone - Live in El Alto or La Paz Bolivia - Sexually active - Not using the pill, implant, injection, intrauterine device or patch - Want to avoid a pregnancy Exclusion Criteria: - Cannot read Spanish |
Country | Name | City | State |
---|---|---|---|
Bolivia | Centro de Investigacion, Educacion y Servicios | La Paz |
Lead Sponsor | Collaborator |
---|---|
London School of Hygiene and Tropical Medicine | Centro de Investigacion, Educacion y Servicios, International Planned Parenthood Federation |
Bolivia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Knowledge of effective contraception | Score on the knowledge measure | 4 months | |
Other | Perceived norms in relation to using and communicating with partners about contraception | Responses to the perceived norms scales | 4 months | |
Other | Personal agency in using and communicating with partners about contraception | Responses to the personal agency scales | 4 months | |
Other | Intention to use effective contraception | Response to the intention scale | 4 months | |
Other | Intervention 'dose' received | If participants read all, some, most or none of the messages and if they stopped the messages | 4 months | |
Primary | Use of effective contraception | The proportion reporting current use of effective contraception (pill, intrauterine device, injection, implant, patch) | 4 months | |
Primary | Acceptability of at least one method of effective contraception | The proportion reporting that at least one method of effective contraception is acceptable (pill, intrauterine device, injection, implant, patch) | 4 months | |
Secondary | Acceptability of individual effective contraceptive methods | The proportion reporting that individual methods of effective contraception are acceptable (pill, intrauterine device, injection, implant, patch) | 4 months | |
Secondary | Discontinuation of effective contraception | The proportion reporting use of effective contraception at any time during the 4 months (pill, intrauterine device, injection, implant, patch) | 4 months | |
Secondary | Service uptake | The proportion reporting attending a sexual health service during the 4 months | 4 months | |
Secondary | Unintended pregnancy | The proportion reporting that they became pregnant and did not want to become pregnant during the study | 4 months | |
Secondary | Induced abortion | The proportion reporting having an abortion during the study | 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |